Eva Fuentes
Assistant Professor
faculty
Peds Pediatrics, College of Medicine
Research Areas
Biography and Research Information
OverviewAI-generated summary
Eva Fuentes' research interests include therapeutic management for ulcerative colitis and the influence of sample preparation on mitochondrial respiratory function in human platelets. Her work on ulcerative colitis, specifically the risk of colectomy in patients previously treated with anti-TNF drugs, was published in 2024. She also investigates factors affecting mitochondrial respiratory function, with a publication in 2025 examining sample preparation, assay buffer, and instrumental platform impacts. Fuentes has also published on user-generated content and brand image, specifically concerning Airbnb on TikTok, and user preferences for Madrid as a travel destination. Additionally, her research encompasses clinical practice guidelines for managing low-grade cervical lesions using adjuvants, published in 2024. Her scholarship metrics include an h-index of 13, 39 total publications, and 519 total citations. She has collaborated with researchers at the University of Arkansas for Medical Sciences, including Craig Porter, D Sadler, Oleksandra Pavliv, and Shannon Rose.
Metrics
- h-index: 13
- Publications: 41
- Citations: 526
Selected Publications
-
Mitochondrial respiratory function in human platelets: Influence of sample preparation, assay buffer, and instrumental platform (2025)
Research Interests
I am a pediatrician-scientist and my research focuses on physical activity and nutritional interventions as a means to promote optimal development and health trajectories of children.
Grants & Funding
- No FP attached UAMS ACHRI Flow Through Principal Investigator
- No FP attached UAMS ACHRI Flow Through Principal Investigator
- No FP attached UAMS ACHRI Flow Through Principal Investigator
- No FP attached UAMS ACHRI Flow Through Principal Investigator
- No FP attached UAMS ACHRI Flow Through Principal Investigator
- No FP attached UAMS ACHRI Flow Through Principal Investigator
Collaboration Network
Top Collaborators
- A los usuarios de Airbnb les gusta Madrid en otoño
- Los contenidos creados por los usuarios redefinen la imagen de marca: así pasa con Airbnb en TikTok
- Cuando visitar las maravillas del mundo se considera una pesadilla
- Lo que más valoramos de un hotel es la calidad de sus instalaciones
- Cuando visitar las maravillas del mundo se considera una pesadilla
- P822 Therapeutic Management And Risk Of Colectomy In Patients With Acute Severe Ulcerative Colitis And Previous Exposure To Anti-Tnf Drugs. A Cohort Study Of Geteccu
- P822 Therapeutic Management And Risk Of Colectomy In Patients With Acute Severe Ulcerative Colitis And Previous Exposure To Anti-Tnf Drugs. A Cohort Study Of Geteccu
- P822 Therapeutic Management And Risk Of Colectomy In Patients With Acute Severe Ulcerative Colitis And Previous Exposure To Anti-Tnf Drugs. A Cohort Study Of Geteccu
- P822 Therapeutic Management And Risk Of Colectomy In Patients With Acute Severe Ulcerative Colitis And Previous Exposure To Anti-Tnf Drugs. A Cohort Study Of Geteccu
- P822 Therapeutic Management And Risk Of Colectomy In Patients With Acute Severe Ulcerative Colitis And Previous Exposure To Anti-Tnf Drugs. A Cohort Study Of Geteccu
- P822 Therapeutic Management And Risk Of Colectomy In Patients With Acute Severe Ulcerative Colitis And Previous Exposure To Anti-Tnf Drugs. A Cohort Study Of Geteccu
- P822 Therapeutic Management And Risk Of Colectomy In Patients With Acute Severe Ulcerative Colitis And Previous Exposure To Anti-Tnf Drugs. A Cohort Study Of Geteccu
- P822 Therapeutic Management And Risk Of Colectomy In Patients With Acute Severe Ulcerative Colitis And Previous Exposure To Anti-Tnf Drugs. A Cohort Study Of Geteccu
- P822 Therapeutic Management And Risk Of Colectomy In Patients With Acute Severe Ulcerative Colitis And Previous Exposure To Anti-Tnf Drugs. A Cohort Study Of Geteccu
- P822 Therapeutic Management And Risk Of Colectomy In Patients With Acute Severe Ulcerative Colitis And Previous Exposure To Anti-Tnf Drugs. A Cohort Study Of Geteccu
- P822 Therapeutic Management And Risk Of Colectomy In Patients With Acute Severe Ulcerative Colitis And Previous Exposure To Anti-Tnf Drugs. A Cohort Study Of Geteccu
- P822 Therapeutic Management And Risk Of Colectomy In Patients With Acute Severe Ulcerative Colitis And Previous Exposure To Anti-Tnf Drugs. A Cohort Study Of Geteccu
- P822 Therapeutic Management And Risk Of Colectomy In Patients With Acute Severe Ulcerative Colitis And Previous Exposure To Anti-Tnf Drugs. A Cohort Study Of Geteccu
Similar Researchers
Based on overlapping research topics